A detailed history of Tevis Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Tevis Investment Management holds 15,086 shares of NVO stock, worth $1.61 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
15,086
Previous 15,308 1.45%
Holding current value
$1.61 Million
Previous $2.19 Million 17.8%
% of portfolio
1.34%
Previous 1.77%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$119.07 - $145.42 $26,433 - $32,283
-222 Reduced 1.45%
15,086 $1.8 Million
Q2 2024

Jul 23, 2024

SELL
$122.71 - $146.91 $100,990 - $120,906
-823 Reduced 5.1%
15,308 $2.19 Million
Q1 2024

Apr 16, 2024

SELL
$102.11 - $135.92 $89,346 - $118,929
-875 Reduced 5.15%
16,131 $2.07 Million
Q4 2023

Jan 19, 2024

BUY
$87.78 - $105.45 $33,883 - $40,703
386 Added 2.32%
17,006 $1.76 Million
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $755,347 - $1.66 Million
8,306 Added 99.9%
16,620 $1.51 Million
Q2 2023

Aug 01, 2023

SELL
$155.98 - $172.65 $26,672 - $29,523
-171 Reduced 2.02%
8,314 $1.35 Million
Q1 2023

May 02, 2023

SELL
$132.34 - $159.14 $229,477 - $275,948
-1,734 Reduced 16.97%
8,485 $1.35 Million
Q4 2022

Jan 30, 2023

SELL
$102.55 - $135.33 $7,793 - $10,285
-76 Reduced 0.74%
10,219 $1.38 Million
Q3 2022

Nov 07, 2022

BUY
$95.28 - $116.93 $20,008 - $24,555
210 Added 2.08%
10,295 $1.03 Million
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $59,053 - $69,675
572 Added 6.01%
10,085 $1.12 Million
Q1 2022

Aug 05, 2022

BUY
$93.1 - $112.54 $6,423 - $7,765
69 Added 0.73%
9,513 $1.06 Million
Q4 2021

Aug 05, 2022

BUY
$95.88 - $117.08 $905,490 - $1.11 Million
9,444 New
9,444 $1.06 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $241B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Tevis Investment Management Portfolio

Follow Tevis Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tevis Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Tevis Investment Management with notifications on news.